These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8551795)

  • 1. Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis.
    Anderson KM; Seed T; Plate JM; Jajeh A; Meng J; Harris JE
    Leuk Res; 1995 Nov; 19(11):789-801. PubMed ID: 8551795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic changes of apoptosis induced in human chronic myelogenous leukemia "blast" cells by SC41661A (Searle), a selective inhibitor of 5-lipoxygenase.
    Anderson KM; Seed TM; Peng J; Jajeh A; Meng J; Harris JE
    Scanning Microsc; 1994; 8(3):675-84; discussion 684-6. PubMed ID: 7747166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase.
    Anderson KM; Levin J; Jajeh A; Seed T; Harris JE
    Prostaglandins Leukot Essent Fatty Acids; 1993 Apr; 48(4):323-6. PubMed ID: 8497493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells.
    Anderson KM; Seed T; Jajeh A; Dudeja P; Byun T; Meng J; Ou D; Bonomi P; Harris JE
    Anticancer Res; 1996; 16(5A):2589-99. PubMed ID: 8917356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.
    Anderson KM; Seed T; Vos M; Mulshine J; Meng J; Alrefai W; Ou D; Harris JE
    Prostate; 1998 Nov; 37(3):161-73. PubMed ID: 9792133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines.
    Ayyub Khan M; Tateson JE; Hoffbrand AV; Wickremasinghe RG
    Leuk Res; 1993 Mar; 17(3):241-5. PubMed ID: 8450672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cells.
    Anderson KM; Ondrey F; Harris JE
    Clin Biochem; 1992 Feb; 25(1):1-9. PubMed ID: 1551235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-lipoxygenase inhibitors reduce Panc-1 survival: the mode of cell death and synergism of MK886 with gamma linolenic acid.
    Anderson KM; Seed T; Meng J; Ou D; Alrefai WA; Harris JE
    Anticancer Res; 1998; 18(2A):791-800. PubMed ID: 9615721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
    Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ
    Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mode of cell death in H-358 lung cancer cells cultured with inhibitors of 5-lipoxygenase or the free radical spin trap, NTBN.
    Ou D; Bonomi P; Jao W; Jadko S; Harris JE; Anderson KM
    Cancer Lett; 2001 May; 166(2):223-31. PubMed ID: 11311496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretion.
    Anderson KM; Seed T; Ondrey F; Harris JE
    Anticancer Res; 1994; 14(5A):1951-60. PubMed ID: 7847833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
    Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
    J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic and antiproliferative effects of gemcitabine and gemcitabine plus Ara-C on blast cells from patients with blast crisis chronic myeloproliferative disorders.
    Santini V; Bernabei A; Gozzini A; Scappini B; Zoccolante A; D'Ippolito G; Figuccia M; Ferrini PR
    Haematologica; 1997; 82(1):11-5. PubMed ID: 9172997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors.
    Anderson KM; Ondrey FG; Harris JE
    Adv Exp Med Biol; 1999; 469():563-8. PubMed ID: 10667383
    [No Abstract]   [Full Text] [Related]  

  • 15. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.
    Nimmanapalli R; Fuino L; Bali P; Gasparetto M; Glozak M; Tao J; Moscinski L; Smith C; Wu J; Jove R; Atadja P; Bhalla K
    Cancer Res; 2003 Aug; 63(16):5126-35. PubMed ID: 12941844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis.
    Okabe S; Tauchi T; Nakajima A; Sashida G; Gotoh A; Broxmeyer HE; Ohyashiki JH; Ohyashiki K
    Stem Cells Dev; 2007 Jun; 16(3):503-14. PubMed ID: 17610380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death.
    Buyn T; Dudeja P; Harris JE; Ou D; Seed T; Sawlani D; Meng J; Bonomi P; Anderson KM
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jan; 56(1):69-77. PubMed ID: 9044439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blast differentiation in a patient with chronic myeloid leukemia in blast crisis using retinoic acid].
    Burgaleta C; Villalba S; Ferro MT
    Sangre (Barc); 1995 Dec; 40(6):509-12. PubMed ID: 8850236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.
    Wiernik PH; Dutcher JP; Paietta E; Hittelman WN; Vyas R; Strack M; Castaigne S; Degos L; Gallagher RE
    Leukemia; 1991 Jun; 5(6):504-9. PubMed ID: 2056773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
    Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.